Beltavac polymerized cat dander

Beltavac polymerized cat dander is a polymerized (allergoid) extract of cat dander produced by chemical modification with glutaraldehyde. This modification reduces the allergenicity (IgE-binding capacity) while preserving immunogenicity (IgG response), allowing higher and safer dosing for allergen immunotherapy. The extract is characterized by a high Fel d 1 concentration (30 μg/mL) and is adjuvanted with aluminum hydroxide. Beltavac polymerized cat dander is intended for **subcutaneous allergen immunotherapy** in patients with IgE-mediated allergy to cats—mainly allergic rhinoconjunctivitis and asthma—to induce immune tolerance and reduce clinical symptoms. The vaccine is manufactured according to Probeltepharma protocols and is supported by preclinical immunogenicity and clinical safety/effectiveness studies[1][2][3][5][9].

Brand names

Beltavac polymerized cat dander

Other names

Beltavac POLYMERIZED cat danderpolymerized cat dander extractglutaraldehyde-polymerized cat dander